Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (R) Ethyl 3 Hydroxybutyrate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114908129B reveals a novel dehydrogenase mutant for high-purity (R)-4-chloro-3-hydroxybutyric acid ethyl ester production, offering significant cost and supply chain advantages.
Patent CN111705068A reveals a novel ketoreductase route for high-purity (R)-EHB, offering significant cost reduction and scalability for antibiotic intermediates.